{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:43:37Z","timestamp":1782312217068,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T00:00:00Z","timestamp":1276819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T00:00:00Z","timestamp":1276819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Non-excitable muscle membrane indicates critical illness myopathy (CIM) during early critical illness. We investigated predisposing risk factors for non-excitable muscle membrane at onset of critical illness.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We performed sequential measurements of muscle membrane excitability after direct muscle stimulation (dmCMAP) in 40 intensive care unit (ICU) patients selected upon a simplified acute physiology (SAPS-II) score \u2265 20 on 3 successive days within 1 week after ICU admission. We then investigated predisposing risk factors, including the insulin-like growth factor (IGF)-system, inflammatory, metabolic and hemodynamic parameters, as well as suspected medical treatment prior to first occurrence of abnormal dmCMAP. Nonparametric analysis of two-factorial longitudinal data and multivariate analysis were used for statistical analysis.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>22 patients showed abnormal muscle membrane excitability during direct muscle stimulation within 7 (5 to 9.25) days after ICU admission. Significant risk factors for the development of impaired muscle membrane excitability in univariate analysis included inflammation, disease severity, catecholamine and sedation requirements, as well as IGF binding protein-1 (IGFBP-I), but did not include either adjunctive hydrocortisone treatment in septic shock, nor administration of neuromuscular blocking agents or aminoglycosides. In multivariate Cox regression analysis, interleukin-6 remained the significant risk factor for the development of impaired muscle membrane excitability (HR 1.006, 95%-CI (1.002 to 1.011), <jats:italic>P<\/jats:italic> = 0.002).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Systemic inflammation during early critical illness was found to be the main risk factor for development of CIM during early critical illness. Inflammation-induced impairment of growth-factor mediated insulin sensitivity may be involved in the development of CIM.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc9074","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T01:24:38Z","timestamp":1278897878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study"],"prefix":"10.1186","volume":"14","author":[{"given":"Steffen","family":"Weber-Carstens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Deja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Spranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Bubser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus D","family":"Wernecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia D","family":"Spies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Spuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Keh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,18]]},"reference":[{"key":"8503_CR1","doi-asserted-by":"publisher","first-page":"S309","DOI":"10.1097\/CCM.0b013e3181b6e64c","volume":"37","author":"B de Jonghe","year":"2009","unstructured":"de Jonghe B, Lacherade JC, Sharshar T, Outin H: Intensive care unit-acquired weakness: Risk factors and prevention.\n                           Crit Care Med 2009, 37: S309-S315. 10.1097\/CCM.0b013e3181b6e64c","journal-title":"Crit Care Med"},{"key":"8503_CR2","doi-asserted-by":"publisher","first-page":"S299","DOI":"10.1097\/CCM.0b013e3181b6ef67","volume":"37","author":"RD Stevens","year":"2009","unstructured":"Stevens RD, Marshall SA, Cornblath DR, Hoke A, Needham DM, de Jonghe B, Ali NA, Sharshar T: A framework for diagnosing and classifying intensive care unit-acquired weakness.\n                           Crit Care Med 2009, 37: S299-S308. 10.1097\/CCM.0b013e3181b6ef67","journal-title":"Crit Care Med"},{"key":"8503_CR3","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S1388-2457(01)00572-7","volume":"112","author":"W Trojaborg","year":"2001","unstructured":"Trojaborg W, Weimer LH, Hays AP: Electrophysiologic studies in critical illness associated weakness: Myopathy or neuropathy--a reappraisal.\n                           Clin Neurophysiol 2001, 112: 1586-1593. 10.1016\/S1388-2457(01)00572-7","journal-title":"Clin Neurophysiol"},{"key":"8503_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jnnp.2005.070813","volume":"77","author":"JP Lefaucheur","year":"2006","unstructured":"Lefaucheur JP, Nordine T, Rodriguez P, Brochard L: Origin of ICU acquired paresis determined by direct muscle stimulation.\n                           J Neurol Neurosurg Psychiatry 2006, 77: 500-506. 10.1136\/jnnp.2005.070813","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8503_CR5","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1097\/CCM.0b013e3181a92f28","volume":"37","author":"S Weber-Carstens","year":"2009","unstructured":"Weber-Carstens S, Koch S, Spuler S, Spies CD, Bubser F, Wernecke KD, Deja M: Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients.\n                           Crit Care Med 2009, 37: 2632-2637. 10.1097\/CCM.0b013e3181a92f28","journal-title":"Crit Care Med"},{"key":"8503_CR6","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1001\/jama.288.22.2859","volume":"288","author":"B De Jonghe","year":"2002","unstructured":"De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Rapha\u00ebl JC, Outin H, Bastuji-Garin S, Groupe de R\u00e9flexion et d'Etude des Neuromyopathies en R\u00e9animation: Paresis acquired in the intensive care unit: A prospective multicenter study.\n                           JAMA 2002, 288: 2859-2867. 10.1001\/jama.288.22.2859","journal-title":"JAMA"},{"key":"8503_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/mus.20304","volume":"32","author":"CF Bolton","year":"2005","unstructured":"Bolton CF: Neuromuscular manifestations of critical illness.\n                           Muscle Nerve 2005, 32: 140-163. 10.1002\/mus.20304","journal-title":"Muscle Nerve"},{"key":"8503_CR8","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1378\/chest.06-2065","volume":"131","author":"WD Schweickert","year":"2007","unstructured":"Schweickert WD, Hall J: Icu-Acquired weakness.\n                           Chest 2007, 131: 1541-1549. 10.1378\/chest.06-2065","journal-title":"Chest"},{"key":"8503_CR9","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1097\/00003246-200112000-00008","volume":"29","author":"MA de Letter","year":"2001","unstructured":"de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Mech\u00e9 FG: Risk factors for the development of polyneuropathy and myopathy in critically ill patients.\n                           Crit Care Med 2001, 29: 2281-2286. 10.1097\/00003246-200112000-00008","journal-title":"Crit Care Med"},{"key":"8503_CR10","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/S0140-6736(09)60658-9","volume":"373","author":"WD Schweickert","year":"2009","unstructured":"Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP: Early physical and occupational therapy in mechanically ventilated, critically ill patients: A randomised controlled trial.\n                           Lancet 2009, 373: 1874-1882. 10.1016\/S0140-6736(09)60658-9","journal-title":"Lancet"},{"key":"8503_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa052521","volume":"354","author":"G Van den Berghe","year":"2006","unstructured":"Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU.\n                           N Engl J Med 2006, 354: 449-461. 10.1056\/NEJMoa052521","journal-title":"N Engl J Med"},{"key":"8503_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G Van den Berghe","year":"2001","unstructured":"Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients.\n                           N Engl J Med 2001, 345: 1359-1367. 10.1056\/NEJMoa011300","journal-title":"N Engl J Med"},{"issue":"E-Suppl","key":"8503_CR13","first-page":"E100","volume":"82","author":"RA Frost","year":"2004","unstructured":"Frost RA, Lang CH: Alteration of somatotropic function by proinflammatory cytokines.\n                           J Anim Sci 2004,82(E-Suppl):E100-E109.","journal-title":"J Anim Sci"},{"key":"8503_CR14","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1210\/en.2002-0192","volume":"144","author":"CH Lang","year":"2003","unstructured":"Lang CH, Vary TC, Frost RA: Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis.\n                           Endocrinology 2003, 144: 3922-3933. 10.1210\/en.2002-0192","journal-title":"Endocrinology"},{"key":"8503_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","volume":"36","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, European Society of Intensive Care Medicine, European Respiratory Society, International Sepsis Forum, Japanese Association for Acute Medicine, Japanese Society of Intensive Care Medicine, Society of Critical Care Medicine, Society of Hospital Medicine, Surgical Infection Society, World Federation of Societies of Intensive and Critical Care Medicine: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008.\n                           Crit Care Med 2008, 36: 296-327. 10.1097\/01.CCM.0000298158.12101.41","journal-title":"Crit Care Med"},{"key":"8503_CR16","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM\/ESICM\/ACCP\/ATS\/SIS: 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference.\n                           Crit Care Med 2003, 31: 1250-1256. 10.1097\/01.CCM.0000050454.01978.3B","journal-title":"Crit Care Med"},{"issue":"Suppl 1","key":"8503_CR17","first-page":"43","volume":"55","author":"K Reinhart","year":"2006","unstructured":"Reinhart K, Brunkhorst F, Bone H, Gerlach H, Grundling M, Kreymann G, Kujath P, Marggraf G, Mayer K, Meier-Hellmann A, Peckelsen C, Putensen C, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Werdan K: [Diagnosis and therapy of sepsis: Guidelines of the german sepsis society inc. And the german interdisciplinary society for intensive and emergency medicine].\n                           Anaesthesist 2006,55(Suppl 1):43-56.","journal-title":"Anaesthesist"},{"key":"8503_CR18","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"LRJ Gall","year":"1993","unstructured":"Gall LRJ, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a european\/north american multicenter study [published erratum appears in JAMA 1994 may 4;271(17):1321].\n                           JAMA 1993, 270: 2957-2963. 10.1001\/jama.270.24.2957","journal-title":"JAMA"},{"key":"8503_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine.\n                           Intensive Care Med 1996, 22: 707-710. 10.1007\/BF01709751","journal-title":"Intensive Care Med"},{"key":"8503_CR20","volume-title":"Nonparametric analysis of longitudinal data in factorial experiments","author":"E Brunner","year":"2002","unstructured":"Brunner E, Domhof S, Langer F: Nonparametric analysis of longitudinal data in factorial experiments. New York: Wiley & Sons; 2002."},{"key":"8503_CR21","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1210\/jc.2002-020664","volume":"87","author":"D Mesotten","year":"2002","unstructured":"Mesotten D, Delhanty PJ, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van den Berghe G: Regulation of insulin-like growth factor binding protein-1 during protracted critical illness.\n                           J Clin Endocrinol Metab 2002, 87: 5516-5523. 10.1210\/jc.2002-020664","journal-title":"J Clin Endocrinol Metab"},{"key":"8503_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1258\/acb.2008.008160","volume":"46","author":"A Borai","year":"2009","unstructured":"Borai A, Livingstone C, Zarif H, Ferns G: Serum insulin-like growth factor binding protein-1: An improvement over other simple indices of insulin sensitivity in the assessment of subjects with normal glucose tolerance.\n                           Ann Clin Biochem 2009, 46: 109-113. 10.1258\/acb.2008.008160","journal-title":"Ann Clin Biochem"},{"key":"8503_CR23","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1399-6576.2006.01096.x","volume":"50","author":"B Holtfreter","year":"2006","unstructured":"Holtfreter B, Bandt C, Kuhn SO, Grunwald U, Lehmann C, Sch\u00fctt C, Gr\u00fcndling M: Serum osmolality and outcome in intensive care unit patients.\n                           Acta Anaesthesiol Scand 2006, 50: 970-977. 10.1111\/j.1399-6576.2006.01096.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"8503_CR24","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s001340101009","volume":"27","author":"J Garnacho-Montero","year":"2001","unstructured":"Garnacho-Montero J, Madrazo-Osuna J, Garc\u00eda-Garmendia JL, Ortiz-Leyba C, Jim\u00e9nez-Jim\u00e9nez FJ, Barrero-Almod\u00f3var A, Garnacho-Montero MC, Moyano-Del-Estad MR: Critical illness polyneuropathy: Risk factors and clinical consequences. A cohort study in septic patients.\n                           Intensive Care Med 2001, 27: 1288-1296. 10.1007\/s001340101009","journal-title":"Intensive Care Med"},{"key":"8503_CR25","doi-asserted-by":"publisher","first-page":"26550","DOI":"10.1074\/jbc.M212273200","volume":"278","author":"P Gual","year":"2003","unstructured":"Gual P, Gonzalez T, Gr\u00e9meaux T, Barres R, Le Marchand-Brustel Y, Tanti JF: Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes.\n                           J Biol Chem 2003, 278: 26550-26557. 10.1074\/jbc.M212273200","journal-title":"J Biol Chem"},{"key":"8503_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/brain\/110.4.819","volume":"110","author":"DW Zochodne","year":"1987","unstructured":"Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA: Critical illness polyneuropathy. A complication of sepsis and multiple organ failure.\n                           Brain 1987, 110: 819-841. 10.1093\/brain\/110.4.819","journal-title":"Brain"},{"key":"8503_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1472-8206.1995.tb00282.x","volume":"9","author":"F Goubel","year":"1995","unstructured":"Goubel F, Pigot A, Allaf O, Verleye M, Gillardin JM: Endotoxins modify muscle fatigue characteristics.\n                           Fundam Clin Pharmacol 1995, 9: 202-204. 10.1111\/j.1472-8206.1995.tb00282.x","journal-title":"Fundam Clin Pharmacol"},{"key":"8503_CR28","doi-asserted-by":"crossref","first-page":"C770","DOI":"10.1152\/ajpcell.1998.274.3.C770","volume":"274","author":"Q el-Dwairi","year":"1998","unstructured":"el-Dwairi Q, Comtois A, Guo Y, Hussain SN: Endotoxin-Induced skeletal muscle contractile dysfunction: Contribution of nitric oxide synthases.\n                           Am J Physiol 1998, 274: C770-C779.","journal-title":"Am J Physiol"},{"key":"8503_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.archger.2008.02.012","volume":"48","author":"LS Pereira","year":"2009","unstructured":"Pereira LS, Narciso FM, Oliveira DM, Coelho FM, Souza Dda G, Dias RC: Correlation between manual muscle strength and interleukin-6 (IL-6) plasma levels in elderly community-dwelling women.\n                           Arch Gerontol Geriatr 2009, 48: 313-316. 10.1016\/j.archger.2008.02.012","journal-title":"Arch Gerontol Geriatr"},{"key":"8503_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/01.mco.0000165003.16578.2d","volume":"8","author":"RA Frost","year":"2005","unstructured":"Frost RA, Lang CH: Skeletal muscle cytokines: Regulation by pathogen-associated molecules and catabolic hormones.\n                           Curr Opin Clin Nutr Metab Care 2005, 8: 255-263. 10.1097\/01.mco.0000165003.16578.2d","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"8503_CR31","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","volume":"98","author":"F Haddad","year":"2005","unstructured":"Haddad F, Zaldivar F, Cooper DM, Adams GR: Il-6-Induced skeletal muscle atrophy.\n                           J Appl Physiol 2005, 98: 911-917. 10.1152\/japplphysiol.01026.2004","journal-title":"J Appl Physiol"},{"key":"8503_CR32","doi-asserted-by":"crossref","first-page":"R371","DOI":"10.1152\/ajpcell.1997.273.2.C371","volume":"273","author":"CH Lang","year":"1997","unstructured":"Lang CH, Pollard V, Fan J, Traber LD, Traber DL, Frost RA, Gelato MC, Prough DS: Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin.\n                           Am J Physiol 1997, 273: R371-R378.","journal-title":"Am J Physiol"},{"key":"8503_CR33","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1210\/en.140.9.3962","volume":"140","author":"RA Frost","year":"1999","unstructured":"Frost RA, Lang CH: Differential effects of insulin-like growth factor I (IGF-I) and igf-binding protein-1 on protein metabolism in human skeletal muscle cells.\n                           Endocrinology 1999, 140: 3962-3970. 10.1210\/en.140.9.3962","journal-title":"Endocrinology"},{"key":"8503_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.CCM.0000157969.46388.A2","volume":"33","author":"S Bercker","year":"2005","unstructured":"Bercker S, Weber-Carstens S, Deja M, Grimm C, Wolf S, Behse F, Busch T, Falke KJ, Kaisers U: Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome.\n                           Crit Care Med 2005, 33: 711-715. 10.1097\/01.CCM.0000157969.46388.A2","journal-title":"Crit Care Med"},{"key":"8503_CR35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/mus.10233","volume":"26","author":"HW Sander","year":"2002","unstructured":"Sander HW, Golden M, Danon MJ: Quadriplegic areflexic ICU illness: Selective thick filament loss and normal nerve histology.\n                           Muscle Nerve 2002, 26: 499-505. 10.1002\/mus.10233","journal-title":"Muscle Nerve"},{"key":"8503_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00134-004-2509-9","volume":"31","author":"R Amaya-Villar","year":"2005","unstructured":"Amaya-Villar R, Garnacho-Montero J, Garcia-Garmendia JL, Madrazo-Osuna J, Garnacho-Montero MC, Luque R, Ortiz-Leyba C: Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease.\n                           Intensive Care Med 2005, 31: 157-161. 10.1007\/s00134-004-2509-9","journal-title":"Intensive Care Med"},{"key":"8503_CR37","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1097\/CCM.0b013e31819fb507","volume":"37","author":"BM Tang","year":"2009","unstructured":"Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS: Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis.\n                           Crit Care Med 2009, 37: 1594-1603. 10.1097\/CCM.0b013e31819fb507","journal-title":"Crit Care Med"},{"key":"8503_CR38","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/CCM.0B013E3181659669","volume":"36","author":"H Fink","year":"2008","unstructured":"Fink H, Helming M, Unterbuchner C, Lenz A, Neff F, Martyn JA, Blobner M: Systemic inflammatory response syndrome increases immobility-induced neuromuscular weakness.\n                           Crit Care Med 2008, 36: 910-916. 10.1097\/CCM.0B013E3181659669","journal-title":"Crit Care Med"},{"key":"8503_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/147323000803600201","volume":"36","author":"M Deja","year":"2008","unstructured":"Deja M, Hommel M, Weber-Carstens S, Moss M, von Dossow V, Sander M, Pille C, Spies C: Evidence-Based therapy of severe acute respiratory distress syndrome: An algorithm-guided approach.\n                           J Int Med Res 2008, 36: 211-221.","journal-title":"J Int Med Res"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc9074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc9074\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc9074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:13:37Z","timestamp":1728303217000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc9074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,18]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,6]]}},"alternative-id":["8503"],"URL":"https:\/\/doi.org\/10.1186\/cc9074","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,18]]},"assertion":[{"value":"21 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R119"}}